Followers | 134 |
Posts | 3703 |
Boards Moderated | 2 |
Alias Born | 09/11/2003 |
Wednesday, August 24, 2016 2:40:26 PM
Radical Transformation At Metabolix, Inc. (NASDAQ:MBLX)
Metabolix, Inc. (NASDAQ: MBLX) has set itself on a path to transformation. First, the company has announced that it is selling its biopolymer business to a South Korean food company called CJ CheilJedang Corporation for $10 million. The transaction is expected to close next month, subject to customary closing conditions.
What is Metabolix selling?
Metabolix, Inc. (NASDAQ: MBLX) is particularly selling patents and laboratory equipment of its biopolymer business. The assets being sold include the microbial strain platform that has been used to develop the company’s fermentation-based products.
Metabolix has already received $2 million from CJ in connection with the sale of biopolymer assets. The balance of $8 million will be released up the closing of the transaction in mid-September.
Subleasing contract
Besides buying Metabolix’s biopolymer business, CJ has also entered an agreement to sublease space at Metabolix’s plant in Woburn, Massachusetts. However, the financial terms of the subleasing deal weren’t disclosed.
Transformation of the business
After offloading the biopolymer business, the second thing that Metabolix, Inc. (NASDAQ: MBLX) intends to do as part of its transformation is rebranding. The company plans to change its name to Yield10 Bioscience in the coming months. CEO Joseph Shaulson said that the sale of biopolymer operation will enable them to gain more footing in their core business and hopefully generate more value for shareholders.
The CEO added that the focus of the management team at Metabolix is on developing disruptive technologies that help to improve crop yield.
Lean corporate structure
Metabolix, Inc. (NASDAQ: MBLX)’s transformation will see the company have a lean corporate structure once the pending transactions are completed. For instance, the restructured company will only have about 20 staff and its annual cash burn is expected to drop to the vicinity of $5 million.
Financial results – Metabolix, Inc. (NASDAQ: MBLX)
Metabolix, Inc. (NASDAQ:MBLX) generated revenue of less than $2.6 million in 2015, down 7% from the previous year. It logged a loss of $23.7 million in 2015, which was slightly better than a loss of $29.5 million in the prior year.
Recent YTEN News
- Rothamsted Research Grants Yield10 Bioscience an Exclusive, Global Commercial License to Advanced Technology for Producing Omega-3 Products in Camelina • GlobeNewswire Inc. • 06/17/2024 12:32:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/12/2024 08:31:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/10/2024 08:09:03 PM
- Yield10 Bioscience Announces Addition of Camelina to INTERLINE® Herbicide Label • GlobeNewswire Inc. • 05/23/2024 12:32:23 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 08:03:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 08:01:57 PM
- Yield10 Bioscience Announces First Quarter 2024 Financial Results • GlobeNewswire Inc. • 05/15/2024 08:00:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 12:48:23 PM
- Yield10 Bioscience Announces Delisting from Nasdaq • GlobeNewswire Inc. • 05/15/2024 12:30:21 PM
- Form RW - Registration Withdrawal Request • Edgar (US Regulatory) • 05/09/2024 03:15:37 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 05/07/2024 08:01:17 PM
- Yield10 Bioscience Announces 1-for-24 Reverse Stock Split • GlobeNewswire Inc. • 05/01/2024 12:30:00 PM
- Yield10 Bioscience Announces Fourth Quarter and Full Year 2023 Financial Results • GlobeNewswire Inc. • 04/01/2024 08:01:07 PM
- Yield10 Bioscience to Announce Fourth Quarter and Full Year 2023 Financial Results and Host a Conference Call on Monday, April 1, 2024 • GlobeNewswire Inc. • 03/28/2024 08:01:20 PM
- Yield10 Bioscience Announces that the Plant Biosafety Office of the Canadian Food Inspection Agency has Cleared Genome-edited E3902 Camelina for Planting in Canada • GlobeNewswire Inc. • 03/26/2024 12:29:24 PM
- USDA-APHIS Determines that Yield10 Bioscience’s Omega-3 Camelina Varieties May Be Planted and Bred in the United States • GlobeNewswire Inc. • 03/21/2024 12:29:14 PM
- Yield10 Bioscience Reports that Proprietary Varieties of Winter Camelina Show Tolerance to Commonly Used Herbicides in First Field Tests • GlobeNewswire Inc. • 02/29/2024 01:31:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2024 09:37:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 03:09:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 11:29:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 11:26:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 11:25:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 05:45:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 04:34:18 PM
- Yield10 Bioscience Grants Global License to VISION Bioenergy Oilseeds for Herbicide Tolerant Camelina Cultivated for the Production of Biofuel Feedstock • GlobeNewswire Inc. • 02/14/2024 02:00:48 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM